Analyst consensus rating

Autolus Therapeutics Analyst Rating: Strong Buy

Direct answer

Autolus Therapeutics's consensus rating is Strong Buy.

8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.36.
Forecast evidence checked November 19, 2026.

Get free Autolus Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$1.08
Average price target
$8.36
High price target
$11.00
Low price target
$5.00
Low target gap
+363.1%
Target upside
+674.6%
High target gap
+918.9%
Target range width
555.8%
Consensus rating
Strong Buy
Analysts
8
Evidence date
November 19, 2026
Valid through
November 26, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Autolus Therapeutics?

Autolus Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $8.36.

How far are Autolus Therapeutics's low and high targets from the recorded price?

The low target implies +363.1%, while the high target implies +918.9%.

How many analysts are included in Autolus Therapeutics's consensus?

The verified consensus includes 8 analysts.

How is Autolus Therapeutics's target upside or downside calculated?

The average target of $8.36 is divided by the recorded price of $1.08, then one is subtracted to produce +674.6%. This does not guarantee a future return.

When was Autolus Therapeutics's analyst forecast verified?

The data was verified on 2026-11-19. The dataset is valid through 2026-11-26.